Press Releases Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Delayed NSE India S.E. Other stock markets 02:40:29 2024-06-25 EDT			5-day change	1st Jan Change
1,498 ^INR	+0.25%		-1.54%	+18.91%

05:14am	Sun Pharma Completes Taro Pharmaceutical Industries Merger	MT
06-22	Sun Pharmaceutical Industries Limited Announces Results from A Phase 1, Multiple Ascending-Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Gl0034 (Utreglutide) in Obese Adults	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sun Pharma - Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis	06-17	AQ
Taro Shareholders Approve Merger with Sun Pharma	05-23	AQ
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger	05-09	AQ
Sun Pharma Canada Launches (PR)WINLEVI® (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne	23-09-27	AQ
Pharmazz Inc. and Sun Pharma enter into licensing agreement for introducing Tyvalzi in India	23-09-14	AQ
Another US Patent Litigation Win For Orexo AB's ZUBSOLV®	23-09-13	AQ
Orexo's patent win for ZUBSOLV[®] appealed	23-07-24	AQ
Orexo wins patent litigation for ZUBSOLV in the US	23-07-03	AQ
Orexo wins patent litigation for ZUBSOLV® in the US	23-07-01	AQ
Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne	23-06-26	AQ
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY in Europe, Australia and New Zealand	23-05-31	AQ
Sun Pharma Announces China NMPA Approval for ILUMETRI for Treatment of Adults with Moderate-To-Severe Plaque Psoriasis	23-05-31	AQ
SUN PHARMA - LATE-BREAKING PHASE 3 DATA AT AAD 2023 SHOW ORAL INVESTIGATIONAL MEDICINE DEURUXOLITINIB SIGNIFICANTLY IMPROVED SCALP HAIR REGROWTH IN ALOPECIA AREATA	23-03-20	AQ
Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of neonatal seizures	22-11-21	AQ
Sun Pharmaceutical Industries : Litigations/Disputes/Regulatory actions	22-03-23	PU
COSMO PHARMACEUTICALS - FULL-YEAR RESULTS 2021, CONFIRMS BEATING GUIDANCE	22-03-23	AQ
Sun Pharma launches PrCEQUA, the first dry eye treatment with nanomicellar technology, in Canada	22-01-28	AQ
Sun Pharmaceutical Industries : Dividend Updates	22-01-25	PU
Sun Pharmaceutical Industries : Loss of Share Certificates	22-01-23	PU
Sun Pharma to announce third quarter results on January 31, 2022	22-01-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Press Releases

Filters